Abstract:Immunoinformatic tools can be used to predict schistosome-specific B-cell epitopes with little sequence identity to human proteins and antigens other than the target. This study reports an approach for identifying schistosome peptides mimicking linear B-cell epitopes using in-silico tools and peptide microarray immunoassay validation. Firstly, a comprehensive literature search was conducted to obtain published schistosome-specific peptides and recombinant proteins with the best overall diagnostic performances. For novel peptides, linear B-cell epitopes were predicted from target recombinant proteins using ABCpred, Bcepred and BepiPred 2.0 in-silico tools. Together with the published peptides, predicted peptides with the highest probability of being B-cell epitopes and the lowest sequence identity with proteins from human and other pathogens were selected. Antibodies against the peptides were measured in sera, using peptide microarray immunoassays. Area under the ROC curve was calculated to assess the overall diagnostic performances of the peptides. Peptide AA81008-19-30 had excellent and acceptable diagnostic performances for discriminating S . mansoni and S . haematobium positives from healthy controls, with AUC values of 0.8043 and 0.7326 respectively for IgG. Peptides MS3_10186-123-131, MS3_10385-339-354, SmSPI-177-193, SmSPI-379-388, MS3-10186-40-49 and SmS-197-214 had acceptable diagnostic performances for discriminating S . mansoni positives from healthy controls with AUC values ranging from 0.7098 to 0.7763 for IgG. Peptides SmSPI-359-372, Smp126160-438-452 and MS3 10186-25-41 had acceptable diagnostic performances for discriminating S . mansoni positives from S . mansoni negatives with AUC values of 0.7124, 0.7156 and 0.7115 respectively for IgG. Peptide MS3-10186-40-49 had an acceptable diagnostic performance for discriminating S . mansoni positives from healthy controls, with an AUC value of 0.7413 for IgM. One peptide with a good diagnostic performance and nine peptides with acceptable diagnostic performances were identified using the immunoinformatic approach and peptide microarray validation. There is need for evaluation of the peptides with true negatives and a good standard positive reference. Schistosomiasis, commonly known as bilharzia, is the third most significant tropical disease after malaria and soil-transmitted helminthiases. Like other neglected tropical diseases common in Zimbabwe, schistosomiasis remains mostly undiagnosed or undetected. This is partly due to the fact that reliable identification of parasites requires expertise for specimen preparation, and microscopic examination. Unfortunately, this level of expertise is unavailable in most rural clinics. This limitation is further compounded by the fact that the recommended microscopy-based methods for schistosomiasis diagnosis lack sensitivity, especially in infections of low intensity. To overcome some of the problems associated with microscopy-based methods, highly sensitive serological tests have been utilized. Unfortunately, currently available serological tests have low specificity and show cross-reactivity with other helminthic infections. One way to mitigate cross-reactivity and increase the specificity, is to use immunoinformatic tools and immunoassays to identify schistosomiasis species-specific immunogenic peptides mimicking B-cell epitopes (short amino acid sequences of the antigen that reacts with antibodies). Utilizing immunoinformatic tools coupled with peptide microarray immunoassay validation approach several peptides that can be used to develop diagnostic tools for showing exposure to infection for people living in non-endemic or low-transmission areas were identified in the current study.

Multi-epitope protein production and its application in the diagnosis of opisthorchiasis

Differential Diagnosis of Cystic and Alveolar Echinococcosis Using an Immunochromatographic Test Based on the Detection of Specific Antibodies

Production and immunological characterization of the novel single-chain variable fragment (scFv) antibodies against the epitopes on Opisthorchis viverrini cathepsin F ( Ov CatF)

Asparaginyl endopeptidase from the carcinogenic liver fluke, Opisthorchis viverrini, and its potential for serodiagnosis

Novel Potential Biomarkers for Opisthorchis viverrini Infection and Associated Cholangiocarcinoma

Rapid and simultaneous multiepitope antigen-based detection of Enterococcus by microscale thermophoresis and immunomagnetic separation

Current State of Knowledge on Blood and Tissue-Based Biomarkers for Opisthorchis viverrini-induced Cholangiocarcinoma: A Review of Prognostic, Predictive, and Diagnostic Markers

Recombinant Multiepitope Protein for Diagnosis of Leptospirosis

Development of a Point-of-Care Immunochromatographic Test Based on Rhoptry Protein 14 for Serological Detection of Toxoplasma Gondii Infection in Swine

Identification of Myoferlin, a Potential Serodiagnostic Antigen of Clonorchiasis, via Immunoproteomic Analysis of Sera From Different Infection Periods and Excretory-Secretory Products of Clonorchis sinensis

Identification of Schistosoma haematobium and Schistosoma mansoni linear B-cell epitopes with diagnostic potential using in silico immunoinformatic tools and peptide microarray technology

Cloning, Expression and Evaluation of Thioredoxin Peroxidase-1 Antigen for the Serological Diagnosis of Schistosoma mekongi Human Infection

Improved diagnostic sensitivity of human strongyloidiasis using point-of-care mixed recombinant antigen-based immunochromatography

Direct detection of Strongyloides infection via molecular and antigen detection methods

Construction and validation of a novel multi-epitope in silico vaccine design against the paramyosin protein of Opisthorchis viverrini using immunoinformatics analyses

An integrated immunoproteomics and bioinformatics approach for the analysis of Schistosoma japonicum tegument proteins.

A point-of-care testing assay for clonorchiasis using a EuNPs-CsTR1 fluorescent probe-based immunoassay

Investigation of a Serine Protease Inhibitor Active in the Infectious Stage of the Human Liver Fluke Opisthorchis viverrini

Production and evaluation of a new set of recombinant antigens for the serological diagnosis of human cysticercosis

Optimization of In-House Indirect-ELISA & EITB Assays Employing Cysticercus cellulosae Antigens for Serological Detection and PCR Assays for Molecular Detection of Porcine Cysticercosis

Epigenetic Biomarkers and the Wnt/β-Catenin Pathway in Opisthorchis viverrini-associated Cholangiocarcinoma: A Scoping Review on Therapeutic Opportunities